Skip to content

Efficacy and safety of washed microbiota transplantation in the treatment of diabetic gastrointestinal motility diasorders

Efficacy and safety of washed microbiota transplantation in the treatment of diabetic gastrointestinal motility disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087518
Enrollment
Unknown
Registered
2024-07-29
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes gastrointestinal motility disorder

Interventions

Washed Microbiota Transplantation group:Washed Microbiota Transplantation

Sponsors

The Second Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with type 1 or type 2 diabetic gastrointestinal motility disorders (including diabetic gastroparesis, diabetic diarrhea, diabetic constipation, etc.); 2. Age between 18 and 75 years old; 3. Glycosylated hemoglobin (HbA1c) <11%; 4. Inadequate response to conventional treatments for at least twelve weeks and willing to undergo washed microbiota transplantation. 5.Willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of antibiotic use for more than 3 consecutive days within the past 3 months. 2.History of active infection and gastrointestinal diseases such as inflammatory bowel disease and irritable bowel syndrome. 3.Definite diagnosis of severe gastrointestinal organic diseases such as gastrointestinal obstruction through digestive tract imaging or gastroscopy. 4.Severe complications of diabetes (including diabetic ketoacidosis, hyperosmolar hyperglycemic syndrome, lactic acidosis, hypoglycemia, etc.). 5.Thyroid diseases, severe cognitive dysfunction and mental illnesses, severe renal insufficiency. 6.Known history of alcohol or drug abuse. 7.Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Gastroparesis Symptom Index ;Gastrointestinal Symptom Rating Scale ;

Secondary

MeasureTime frame
Composite Autonomic Symptom Score ;Gastrointestinal motility ;Heart rate variability ;

Countries

China

Contacts

Public ContactDafa Ding

The Second Affiliated Hospital of Nanjing Medical University

dingdafa@njmu.edu.cn+86 158 5051 4014

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026